CMMB

Chemomab Therapeutics

14 hedge funds and large institutions have $4.91M invested in Chemomab Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$1.87M 1,614,134 +1,496,974 +1,278%
O
2
OrbiMed
New York
$1.09M 940,990 -800,283 -46%
SFM
3
Sphera Funds Management
Israel
$856K 738,048 -162,380 -18%
YLHM
4
Yelin Lapidot Holdings Management
Israel
$671K 578,291
IC
5
Ikarian Capital
Texas
$247K 213,052
RhumbLine Advisers
6
RhumbLine Advisers
Massachusetts
$46.2K 39,875 +16,026 +67%
KPWS
7
Kestra Private Wealth Services
Texas
$36.2K 31,241
BFM
8
Boothbay Fund Management
New York
$30.4K 26,189
Jane Street
9
Jane Street
New York
$23.9K 20,569 +20,569 New
BNP Paribas Financial Markets
10
BNP Paribas Financial Markets
France
$16.1K 13,900 +3,400 +32%
GI
11
GAMMA Investing
California
$14.9K 12,811 +1,783 +16%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$1.37K 1,180 +1,180 New
UBS Group
13
UBS Group
Switzerland
$461 397 -486 -55%
SS
14
SBI Securities
Japan
$129 111 +7 +7%
VF
15
Virtu Financial
New York
-30,803 Closed
TSS
16
Two Sigma Securities
New York
-22,104 Closed
XT
17
XTX Topco
Cayman Islands
-13,274 Closed
WIA
18
Wetzel Investment Advisors
Indiana
-11,000 Closed
MWA
19
Moser Wealth Advisors
Washington
-500 Closed